Stephanie Russell
Family · Beavercreek, OHNPI 1891019758
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.3% of the total across 302 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 40.6% of the total. Reporting peaked in 2021 at $1,450 and has fallen 68.0% since, to $463 in 2025. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 302 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$542
- Lilly USA, LLC$357
- Novartis$329
- E.r. Squibb & Sons, L.L.C.$307
- Pfizer$153
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,57095%
- Education$2275%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 143 | $1,950 |
| Johnson & Johnson | 33 | $542 |
| Lilly USA, LLC | 19 | $357 |
| Novartis | 17 | $329 |
| E.r. Squibb & Sons, L.L.C. | 21 | $307 |
| Pfizer | 8 | $153 |
| Sun Pharmaceutical Industries Inc. | 4 | $131 |
| Galderma Laboratories, L.p. | 8 | $130 |
| VYNE Pharmaceuticals Inc. | 9 | $120 |
| Incyte Corporation | 5 | $114 |
| Almirall LLC | 5 | $92 |
| LEO Pharma Inc. | 5 | $89 |
| Regeneron Healthcare Solutions, Inc. | 4 | $87 |
| Sanofi | 3 | $59 |
| Verrica Pharmaceuticals Inc. | 2 | $47 |
| Arcutis Biotherapeutics, Inc. | 3 | $47 |
| Boehringer Ingelheim | 2 | $45 |
| Amgen | 2 | $43 |
| UCB, Inc. | 2 | $33 |
| Dermavant Sciences, Inc. | 2 | $31 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $31 |
| Krystal Biotech Inc | 1 | $22 |
| Merz North America, Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $17 |
How this compares
$4,797 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $89,965 |
| Fluorouracil | 16 | $1,685 |
| Fluocinonide | 16 | $973 |
| Clobetasol Propionate | 27 | $932 |
| Gentamicin Sulfate | 17 | $770 |
| Betamethasone Dipropionate | 16 | $761 |
| Ketoconazole | 42 | $730 |
| Doxycycline Hyclate | 35 | $350 |
| Fluconazole | 17 | $277 |
| Minocycline Hcl | 15 | $267 |
| Triamcinolone Acetonide | 30 | $171 |
| Mupirocin | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other family in Beavercreek
- Jenna McConnellBeavercreek$15K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.